Abstract
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Clinical Chemistry |
| Vol/bind | 53 |
| Udgave nummer | 11 |
| Sider (fra-til) | 1928-35 |
| Antal sider | 7 |
| ISSN | 0009-9147 |
| DOI | |
| Status | Udgivet - 2007 |
Bibliografisk note
Keywords: Adult; Age Factors; Aged; Aged, 80 and over; Body Mass Index; Chronic Disease; Female; Glomerular Filtration Rate; Heart Failure; Humans; Linear Models; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide FragmentsAdgang til dokumentet
Biblioteksadgang?
Tjek tilgængelighed hos det Kgl. BibliotekCitationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
I: Clinical Chemistry, Bind 53, Nr. 11, 2007, s. 1928-35.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
}
TY - JOUR
T1 - Effects of body mass index and age on N-terminal pro brain natriuretic peptide are associated with glomerular filtration rate in chronic heart failure patients.
AU - Schou, Morten
AU - Gustafsson, Finn
AU - Kistorp, Caroline N
AU - Corell, Pernille
AU - Kjaer, Andreas
AU - Hildebrandt, Per R
N1 - Keywords: Adult; Age Factors; Aged; Aged, 80 and over; Body Mass Index; Chronic Disease; Female; Glomerular Filtration Rate; Heart Failure; Humans; Linear Models; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments
PY - 2007
Y1 - 2007
N2 - BACKGROUND: Obesity is a state characterized by glomerular hyperfiltration and age-related decreases in glomerular filtration rate (GFR). Body mass index (BMI), age, and GFR are associated with plasma concentrations of N-terminal pro-brain natriuretic peptide (NT-proBNP) in chronic heart failure (CHF) patients. We hypothesized that the effects of BMI and age on plasma concentrations of NT-proBNP are associated with GFR. METHODS: We obtained clinical data and laboratory test results from 345 CHF patients at the baseline visit in our heart failure clinic and examined the hypothesis using multiple linear regression models. RESULTS: Age (P = 0.0184), BMI (P = 0.0098), hemoglobin (P = 0.0043), heart rhythm (P <0.0001), and left ventricular ejection fraction (P <0.0001) were associated with log(NT-proBNP). After adjustment for GFR estimated by the Cockcroft and Gault equation, the parameter estimates for BMI (P = 0.3807) and age (P = 0.7238) changed markedly and became insignificant. In another model, after adjustment for GFR estimated by the 4-component Modification of Diet in Renal Disease formula (eGFR(MDRD)), the parameter estimates for age (P = 0.0674) changed markedly and became insignificant, but BMI (P = 0.0067) remained significant and unchanged. The eGFR(MDRD) is adjusted for body surface area, which may explain the difference. CONCLUSIONS: In CHF patients, the effect of age on NT-proBNP is associated with estimates for GFR derived from serum creatinine, and the significance of the effects of BMI on NT-proBNP depends on the method by which GFR is estimated.
AB - BACKGROUND: Obesity is a state characterized by glomerular hyperfiltration and age-related decreases in glomerular filtration rate (GFR). Body mass index (BMI), age, and GFR are associated with plasma concentrations of N-terminal pro-brain natriuretic peptide (NT-proBNP) in chronic heart failure (CHF) patients. We hypothesized that the effects of BMI and age on plasma concentrations of NT-proBNP are associated with GFR. METHODS: We obtained clinical data and laboratory test results from 345 CHF patients at the baseline visit in our heart failure clinic and examined the hypothesis using multiple linear regression models. RESULTS: Age (P = 0.0184), BMI (P = 0.0098), hemoglobin (P = 0.0043), heart rhythm (P <0.0001), and left ventricular ejection fraction (P <0.0001) were associated with log(NT-proBNP). After adjustment for GFR estimated by the Cockcroft and Gault equation, the parameter estimates for BMI (P = 0.3807) and age (P = 0.7238) changed markedly and became insignificant. In another model, after adjustment for GFR estimated by the 4-component Modification of Diet in Renal Disease formula (eGFR(MDRD)), the parameter estimates for age (P = 0.0674) changed markedly and became insignificant, but BMI (P = 0.0067) remained significant and unchanged. The eGFR(MDRD) is adjusted for body surface area, which may explain the difference. CONCLUSIONS: In CHF patients, the effect of age on NT-proBNP is associated with estimates for GFR derived from serum creatinine, and the significance of the effects of BMI on NT-proBNP depends on the method by which GFR is estimated.
U2 - 10.1373/clinchem.2006.084426
DO - 10.1373/clinchem.2006.084426
M3 - Journal article
C2 - 17872942
SN - 0009-9147
VL - 53
SP - 1928
EP - 1935
JO - Clinical Chemistry
JF - Clinical Chemistry
IS - 11
ER -